Literature DB >> 6799949

Spironolactone and diabetic ketoacidosis.

A G Jariwalla, C R Jones, A Lever, R Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6799949      PMCID： PMC2426150          DOI： 10.1136/pgmj.57.671.573

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Serum phosphorus and potassium levels after intravenous administration of glucose; their use as diagnostic acids in diabetic and nondiabetic subjects with and without liver disease.

Authors:  K GUNDERSEN; R F BRADLEY; A MARBLE
Journal:  N Engl J Med       Date:  1954-04-01       Impact factor: 91.245

2.  Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870).

Authors:  J L McNay; E Oran
Journal:  Metabolism       Date:  1970-01       Impact factor: 8.694

3.  Fatal hyperkalemic paralysis associated with spironalactone. Observation on a patient with severe renal disease and refractory edema.

Authors:  E Herman; J Rado
Journal:  Arch Neurol       Date:  1966-07

4.  Spironolactone. I. Disposition and metabolism.

Authors:  A Karim; J Zagarella; J Hribar; M Dooley
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.